What Makes Eli Lilly And Co. (LLY) a Worthy Holding?

Alpha Wealth Funds, LLC, an investment management company, released its Q3 2025 letter for the “Insiders Fund”. A copy of the letter can be downloaded here. The fund returned 4.96% in September, bringing the YTD returns to 21.37%. This compares to the benchmark, S&P 500 September return of 3.65% and the year-to-date return through September 30, 2025, of 14.83%. In addition, please check the fund’s top five holdings to know its best picks in 2025.

In its third-quarter 2025 investor letter, Alpha Wealth Insiders Fund highlighted stocks such as Eli Lilly and Company (NYSE:LLY). Eli Lilly and Company (NYSE:LLY) is a pharmaceutical company headquartered in Indianapolis, Indiana. The one-month return of Eli Lilly and Company (NYSE:LLY) was 5.93%, and its shares gained 38.12% of their value over the last 52 weeks. On December 31, 2025, Eli Lilly and Company (NYSE:LLY) stock closed at $1,074.68 per share, with a market capitalization of $963.404 billion.

Alpha Wealth Insiders Fund stated the following regarding Eli Lilly and Company (NYSE:LLY) in its third quarter 2025 investor letter:

"Business: Eli Lilly and Company (NYSE:LLY) is a pharma powerhouse: maker of Mounjaro and Zepbound in weight-loss/diabetes, blockbuster cancer and immunology drugs, and a booming Alzheimer’s pipeline. Its stock rides the GLP-1 wave, fueling massive growth and market-cap dominance.

Insider Buying/Selling: On Aug 12, 2025, insiders made several purchases: • David A. Ricks (CEO) bought 1,632 shares at $644.77 ($1.05M) • J. Erik Fyrwald (Director) bought 1,565 shares at $642.33 ($1.005M) • Daniel Skovronsky (EVP) bought 1,000 shares at $634.40 ($634.4k) • Gabrielle Sulzberger (Director) bought 117 shares at $641.18 ($75k) • Jamere Jackson (Director) bought 200 shares at ~$639.56 (~$127.9k.

Over the past 12 months, insiders have bought a total of ~$2.89M worth of Lilly shares.…”(Click here to read the full text)

Eli Lilly and Company (NYSE:LLY) is in 21st position on our list of 30 Most Popular Stocks Among Hedge Funds. According to our database, 114 hedge fund portfolios held Eli Lilly and Company (NYSE:LLY) at the end of the third quarter, compared to 119 in the previous quarter. In the third quarter of 2025, Eli Lilly and Company's (NYSE:LLY) revenue grew 54% compared to the same period last year. While we acknowledge the potential of Eli Lilly and Company (NYSE:LLY) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

In another article, we covered Eli Lilly and Company (NYSE:LLY) and shared the list of some of the best dividend stocks. In addition, please check out our hedge fund investor letters Q3 2025 page for more investor letters from hedge funds and other leading investors.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. This article is originally published at Insider Monkey.